Assyro AI

FDA Orange Book · active-ingredient family

Acetaminophen; ibuprofen

Acetaminophen; ibuprofen is approved as 2 brand and 10 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:COMBOGESIC · NDA 209471

2

Brand (NDA)

10

Generics (ANDA)

3

Listed patents

1

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
COMBOGESICRLDAFT PHARMS USNDA 209471Mar 01, 2023
ADVIL DUAL ACTION WITH ACETAMINOPHENRLDHALEON US HOLDINGSNDA 211733Feb 28, 2020

Generic (ANDA) products (10)

ProductApplicantApplicationTEApproved
ACETAMINOPHEN AND IBUPROFENTAROANDA 219053Jan 02, 2026
ACETAMINOPHEN AND IBUPROFENLNK INTL INCANDA 220126Dec 11, 2025
ACETAMINOPHEN AND IBUPROFENSTRIDES PHARMAANDA 217241Jan 17, 2025
ACETAMINOPHEN AND IBUPROFENDR REDDYSANDA 218247Aug 23, 2024
ACETAMINOPHEN AND IBUPROFENGLENMARK PHARMS LTDANDA 218311Apr 26, 2024
ACETAMINOPHEN AND IBUPROFENAUROBINDO PHARMA LTDANDA 218359Mar 26, 2024
ACETAMINOPHEN AND IBUPROFENBIONPHARMAANDA 216999Aug 01, 2023
ACETAMINOPHEN AND IBUPROFENGRANULESANDA 216592Jul 13, 2023
ACETAMINOPHEN AND IBUPROFENMARKSANS PHARMAANDA 216994Jul 10, 2023
ACETAMINOPHEN AND IBUPROFENL PERRIGO COANDA 214836Feb 28, 2023

Marketing exclusivity (1)

  • NPNew product exclusivity (3 years)

    Mar 01, 2026

    4 mo ago

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11534407Feb 27, 2039in 12 yr 11 mo
ProductU-3553
11197830Feb 27, 2039in 12 yr 11 mo
ProductU-3553
11918693Jul 09, 2041in 15 yr 3 mo
Product

Acetaminophen; ibuprofen — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.